Japan · Delayed Price · Currency is JPY MEDINET Company Description
MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan.
It operates through two segments: Cell Processing Business and Regenerative Medicine Products Business.The company’s solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy.It also manufactures regenerative medical/investigational and specified cell products.
In addition, the company offers value chain solutions, such as personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management system, quality control and assurance, and technology transfer and process development solutions.
The company serves medical institutions, research institutions, and biopharmaceutical companies. MEDINET Co., Ltd. was incorporated in 1995 and is headquartered in Tokyo, Japan.
| Country | Japan |
| Founded | 1995 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 92 |
| CEO | Kanenao Kubushiro |
Contact Details
Address: TRC Center Building Tokyo, 143-0006 Japan | |
| Phone | 81 3 6631 1201 |
| Website | medinet-inc.co.jp |
Stock Details
| Ticker Symbol | 2370 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | JPY |
| ISIN Number | JP3920990003 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Kanenao Kubushiro | Chief Executive Officer |